Llwytho...
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
BACKGROUND: Only eight women out of one hundred diagnosed with ovarian epithelial cancers, which progressed to the clinical stage IV, survive 10 years. First line therapies: surgery, chemotherapy, and radiation therapy inflict very serious iatrogenic consequences. Passive immunotherapy of ovarian ca...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Transl Med |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5130937/ https://ncbi.nlm.nih.gov/pubmed/27905089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-016-0125-2 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|